Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Pediatr Nephrol ; 34(3): 495-506, 2019 03.
Artículo en Inglés | MEDLINE | ID: mdl-30397789

RESUMEN

OBJECTIVE: The present study aimed to assess the long-term safety and tolerability of valsartan in hypertensive children aged 6-17 years, with or without chronic kidney disease (CKD). METHODS: This was an 18-month, open-label, multicentre, prospective study conducted in 150 patients with history of hypertension with or without CKD. The primary endpoint was long-term safety and tolerability of valsartan and valsartan-based treatments, assessed in terms of adverse events (AEs), serious AEs, laboratory measurements, estimated glomerular filtration rate (eGFR), urinalysis and electrocardiogram. RESULTS: Of 150 enrolled patients, 117 (78%) completed the study. At week 78, a clinically and statistically significant reduction in mean sitting systolic and diastolic blood pressures was observed in all patients (- 14.9 mmHg and - 10.6 mmHg, respectively). Within the first 3 months of treatment, mean urine albumin creatinine ratio decreased in CKD population, which was sustained. A higher percentage of CKD patients had at least one AE compared to non-CKD patients (85.3% vs. 73.3%, respectively). The majority of AEs were mild (50.7%) or moderate (18.7%) in severity. As expected, in patients with underlying CKD, increases in serum potassium, creatinine and blood urea nitrogen were more commonly reported compared to non-CKD patients. A > 25% decrease in Schwartz eGFR was observed in 28.4% of CKD patients and 13.5% of non-CKD patients. CONCLUSIONS: Valsartan was generally well tolerated, with an AE profile consistent with angiotensin receptor blockers in the overall population and in patients with underlying CKD. Long-term efficacy was maintained and a beneficial effect on proteinuria was observed.


Asunto(s)
Bloqueadores del Receptor Tipo 1 de Angiotensina II/efectos adversos , Hipertensión/tratamiento farmacológico , Proteinuria/tratamiento farmacológico , Insuficiencia Renal Crónica/complicaciones , Valsartán/efectos adversos , Adolescente , Bloqueadores del Receptor Tipo 1 de Angiotensina II/administración & dosificación , Presión Sanguínea/efectos de los fármacos , Niño , Tos/inducido químicamente , Tos/diagnóstico , Tos/epidemiología , Creatinina/sangre , Creatinina/orina , Quimioterapia Combinada/efectos adversos , Quimioterapia Combinada/métodos , Femenino , Fiebre/inducido químicamente , Fiebre/diagnóstico , Fiebre/epidemiología , Tasa de Filtración Glomerular , Cefalea/inducido químicamente , Cefalea/diagnóstico , Cefalea/epidemiología , Humanos , Hipertensión/sangre , Hipertensión/etiología , Hipertensión/orina , Masculino , Nasofaringitis/inducido químicamente , Nasofaringitis/diagnóstico , Nasofaringitis/epidemiología , Estudios Prospectivos , Proteinuria/sangre , Proteinuria/etiología , Proteinuria/orina , Insuficiencia Renal Crónica/sangre , Insuficiencia Renal Crónica/tratamiento farmacológico , Insuficiencia Renal Crónica/orina , Albúmina Sérica Humana/orina , Índice de Severidad de la Enfermedad , Factores de Tiempo , Resultado del Tratamiento , Valsartán/administración & dosificación
2.
Rev Assoc Med Bras (1992) ; 64(12): 1081-1084, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-30569983

RESUMEN

OBJECTIVE: Halzoun syndrome, also known as nasopharyngeal linguatulosis, is a rare entity that is mostly prevalent in Eastern Mediterranean countries. The consumption of raw ovine liver and lymph nodes infested with Linguatula serrata nymphs remains a major cause of the nasopharyngeal symptoms and discomfort associated with the disease. Halzoun syndrome is a clinical diagnosis based on history and presentation. METHODS: Treatment of this disease is still debated; however, our experience reveals that alcohol gargle can be a good option. Proper counselling on the hazards of eating raw liver in endemic areas is needed. RESULTS: Moreover, physicians should be aware of the sequence of events in the disease in order not to delay or miss the diagnosis. CONCLUSIONS: This communication presents a rare Lebanese case of Halzoun syndrome that offers medical implications in the clinical diagnosis and treatment of the nasopharyngeal symptoms of this syndrome, with a review of the literature.


Asunto(s)
Enfermedades Transmitidas por los Alimentos/parasitología , Nasofaringitis/parasitología , Enfermedades Parasitarias/parasitología , Pentastomida , Animales , Femenino , Enfermedades Transmitidas por los Alimentos/diagnóstico , Enfermedades Transmitidas por los Alimentos/tratamiento farmacológico , Humanos , Nasofaringitis/diagnóstico , Nasofaringitis/tratamiento farmacológico , Enfermedades Parasitarias/diagnóstico , Enfermedades Parasitarias/tratamiento farmacológico , Adulto Joven
3.
Rev. Assoc. Med. Bras. (1992, Impr.) ; Rev. Assoc. Med. Bras. (1992, Impr.);64(12): 1081-1084, Dec. 2018. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1041013

RESUMEN

SUMMARY Halzoun syndrome, also known as nasopharyngeal linguatulosis, is a rare entity that is mostly prevalent in Eastern Mediterranean countries. The consumption of raw ovine liver and lymph nodes infested with Linguatula serrata nymphs remains a major cause of the nasopharyngeal symptoms and discomfort associated with the disease. Halzoun syndrome is a clinical diagnosis based on history and presentation. Treatment of this disease is still debated; however, our experience reveals that alcohol gargle can be a good option. Proper counselling on the hazards of eating raw liver in endemic areas is needed. Moreover, physicians should be aware of the sequence of events in the disease in order not to delay or miss the diagnosis. This communication presents a rare Lebanese case of Halzoun syndrome that offers medical implications in the clinical diagnosis and treatment of the nasopharyngeal symptoms of this syndrome, with a review of the literature.


RESUMO Esta comunicação apresenta um caso libanês raro de síndrome de Halzoun que oferece implicações médicas no diagnóstico clínico e no tratamento dos sintomas nasofaríngeos desta síndrome, com uma revisão da literatura. A síndrome de Halzoun, também conhecida como linguatulose nasofaríngea, é uma entidade rara predominante nos países do Mediterrâneo Oriental. O consumo de linfonodos ovinos e linfáticos ovinos infestados com ninfas Linguatula serrata continua a ser uma das principais causas dos sintomas nasofaríngeos e do desconforto associado à doença. A síndrome de Halzoun é um diagnóstico clínico baseado na história e na apresentação. O tratamento dessa doença ainda é debatido; no entanto, nossos resultados revelam que o gargarismo de álcool pode ser uma boa opção. É necessário um aconselhamento adequado sobre os perigos de comer fígado cru em áreas endêmicas. Além disso, os médicos devem estar cientes da sequência de eventos na doença, a fim de não atrasar ou perder o diagnóstico.


Asunto(s)
Humanos , Animales , Femenino , Adulto Joven , Enfermedades Parasitarias/parasitología , Nasofaringitis/parasitología , Pentastomida , Enfermedades Transmitidas por los Alimentos/parasitología , Enfermedades Parasitarias/diagnóstico , Enfermedades Parasitarias/tratamiento farmacológico , Nasofaringitis/diagnóstico , Nasofaringitis/tratamiento farmacológico , Enfermedades Transmitidas por los Alimentos/diagnóstico , Enfermedades Transmitidas por los Alimentos/tratamiento farmacológico
4.
Genet Mol Res ; 14(4): 16403-9, 2015 Dec 09.
Artículo en Inglés | MEDLINE | ID: mdl-26662436

RESUMEN

The aim of this study was to investigate the expression of LRRC4 in nasopharyngeal carcinomas, nasopharyngeal precancerous lesions, and nasopharyngitis as well as the clinical significance of LRRC4. Fifty patients with nasopharyngeal carcinoma were selected as study subjects; 28 patients with chronic nasopharyngitis and 22 patients with nasopharyngeal precancerous lesions served as controls. Immunohistochemical analysis was used to study protein expression of LRRC4; the relation between LRRC4 expression and the clinical stage and histopathological features of nasopharyngeal carcinoma was also analyzed. The LRRC4 expression manifested itself as yellow staining in the cytoplasm or nucleus. LRRC4 was strongly expressed in nasopharyngeal epithelial tissues of patients with chronic nasopharyngitis and in nasopharyngeal precancerous lesions; the rates of positive results were 82.1 and 81.8%, respectively. LRRC4 was weakly expressed in nasopharyngeal carcinoma tissues, at a rate of 10% positive results (P< 0.001); there was no significant difference in the expression of LRRC4 among different clinical stages and pathological grades. Therefore, disappearance of LRRC4 expression is a major feature of nasopharyngeal carcinoma.


Asunto(s)
Enfermedades Nasofaríngeas/metabolismo , Neoplasias Nasofaríngeas/metabolismo , Proteínas del Tejido Nervioso/metabolismo , Adulto , Carcinoma , Femenino , Expresión Génica , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Membrana Mucosa/metabolismo , Membrana Mucosa/patología , Carcinoma Nasofaríngeo , Enfermedades Nasofaríngeas/diagnóstico , Enfermedades Nasofaríngeas/genética , Neoplasias Nasofaríngeas/diagnóstico , Neoplasias Nasofaríngeas/genética , Nasofaringitis/diagnóstico , Nasofaringitis/genética , Estadificación de Neoplasias , Proteínas del Tejido Nervioso/genética , Lesiones Precancerosas , Pronóstico , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA